Duvelisib

OncoPharm
26/09/2018 18 min
Duvelisib

Listen "Duvelisib"

Descargar episodio Ver en sitio original

Episode Synopsis

The latest #oncopharm approval for duvelisib is discussed as well as the similarities and differences to other PI3K inhibitors previously approved.
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA